Concepedia

Author

Élodie Pramil

Sorbonne UniversitéORCID

Also Known As

E. Pramil, Elodie Pramil, Élodie Pramil

17

Publications

208

Citations

8

H-Index

11

Concepts

All Affiliations

Sorbonne UniversitéInsermAssistance Publique – Hôpitaux de ParisUniversité Paris CitéCentre de Recherche des Cordeliers
ÉP

About

Élodie Pramil is an author at Sorbonne Université specializing in cell engineering, cell transplantation, and tumor biology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

1

1

27

2

Biomedical Engineering

1

1

27

3

Cell Biology

1

1

27

4

Regenerative Medicine

1

1

27

5

Cell Engineering

1

1

27

Élodie Pramil

×

7

Publications

184

Citations

7

H-Index

YearCitations

Genetic characterization of B-cell prolymphocytic leukemia: a prognostic model involving MYC and TP53

Élise Chapiro, Élodie Pramil, M’Boyba Diop,

Blood

2019

51

Thrombospondin-1 Mimetic Agonist Peptides Induce Selective Death in Tumor Cells: Design, Synthesis, and Structure–Activity Relationship Studies

Thomas Denèfle, Héloïse Boullet, Linda Herbi,

Journal of Medicinal Chemistry

2016

41

Engineered mesenchymal stem cells as vectors in a suicide gene therapy against preclinical murine models for solid tumors

Ikrame Amara, Élodie Pramil, Catherine Sénamaud‐Beaufort,

Journal of Controlled Release

2016

27

Expression Pattern of Purinergic Signaling Components in Colorectal Cancer Cells and Differential Cellular Outcomes Induced by Extracellular ATP and Adenosine

Clémentine Dillard, Chloé Borde, Ammara Mohammad,

International Journal of Molecular Sciences

2021

19

Relation of Neutrophil Gelatinase-Associated Lipocalin Overexpression to the Resistance to Apoptosis of Tumor B Cells in Chronic Lymphocytic Leukemia

Brigitte Bauvois, Élodie Pramil, Ludovic Jondreville,

Cancers

2020

17

Activation of Interferon Signaling in Chronic Lymphocytic Leukemia Cells Contributes to Apoptosis Resistance via a JAK-Src/STAT3/Mcl-1 Signaling Pathway

Brigitte Bauvois, Élodie Pramil, Ludovic Jondreville,

Biomedicines

2021

16

Targeting chronic lymphocytic leukemia with N-methylated thrombospondin-1–derived peptides overcomes drug resistance

Élodie Pramil, Linda Herbi Bastian, Thomas Denèfle,

Blood Advances

2019

13

Page 1